Anand Devaraj

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

Kevin R. Flaherty, Athol U. Wells, Vincent Cottin et al. · New England Journal of Medicine · 2019 · 2.3K citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacotherapy +11

Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease

Kevin M. Brown, Athol U. Wells, Emmanuelle Clerisme-Beaty et al. · BMJ Open Respiratory Research · 2017 · 187 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial

Kevin R. Flaherty, Athol U. Wells, Vincent Cottin et al. · European Respiratory Journal · 2021 · 115 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Visual and Automated CT Measurements of Lung Volume Loss in Idiopathic Pulmonary Fibrosis

Hasti Robbie, Athol U. Wells, Joseph Jacob et al. · American Journal of Roentgenology · 2019 · 53 citations

Medicine, Radiology, Diagnostic Imaging +16

CT and histopathological correlation of congenital cystic pulmonary lesions: a common pathogenesis?

Nyree Griffin, Anand Devaraj, Peter Goldstraw et al. · Clinical Radiology · 2008 · 47 citations

Medicine, Pathology, Radiology +16